Home » Newsletters » BioWorld

BioWorld

May 12, 1994

View Archived Issues

STOCKHOLDER PROPOSALS VOTED DOWN AT SCIOS NOVA

ORPHAN DRUG ACT LEGISLATION ON ITS WAY TO SENATE FLOOR

BIOCODE RAISES $4M PRIVATELY

PATENTS ALLOWANCES

EARNINGS REPORTS

OTHER NEWS TO NOTE

CORTECH PLANS SECOND PHASE II SEPSIS TRIAL

FIRST U.S. ANTISENSE ANTI-HIV HUMAN TRIALS START NEXT WEEK

GREENWICH LAYS OFF MOST OF WORK FORCE

CHIRON'S STOCK JUMPS BASED ON MISCUE

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...